Regulatory T cells specific for the same framework 3 region of the V beta 8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis

Recent evidence indicates that chronic autoimmune disease can result from breakdown of regulation and subsequent activation of self-reactive T cells. In many murine autoimmune disease systems and in the Lewis rat, antigen-specific T cells utilizing the T cell receptor (TCR) V beta 8.2 gene segment play a major role. In the myelin basic protein-induced experimental autoimmune encephalomyelitis (EAE) model in H-2(u) mice, we had shown that T cells recognizing a peptide determinant within the framework 3 region of the V beta 8.2 chain have a critical role in influencing the course of the disease. Here, we report experiments in another disease system, collagen II (CII)-induced arthritis (CIA) in DBA/1LacJ (H-2(q)) mice, indicating a remarkably parallel control circuit to that found for EAE. A critical role is played by CII-specific V beta 8.2-bearing T cells in the CIA system, which we have confined, Animals treated with the superantigen SEE before CII administration are significantly protected from CIA. Next, we tested the ability of peptides encompassing the entire V beta 8.2 chain to induce proliferative responses. Only TCR peptide B5 (amino acids 76-101), a regulator peptide in EAE, induced proliferation. B5 was then used to vaccinate DBA/1LacJ mice and was shown to reduce greatly the severity and incidence of CIA as measured by joint inflammation or histology. Furthermore, similar protection was found when B5 was administered after CII immunization. It was shown that there is physiological induction of a proliferative response to B5 during CIA and that: the determinant within B5 is produced from a single chain TCR construct containing the entire V beta 8.2 chain, Finally, the regulation of CIA is discussed in the context of other experimental autoimmune diseases, especially EAE, with emphasis on what appear to be strikingly common mechanisms.